Cargando…
A Brief Look at Hashimoto’s Disease, Adrenal Incidentalomas, Obesity and Insulin Resistance—Could Endocrine Disruptors Be the Other Side of the Same Coin?
Hashimoto’s disease (HD) is the most common cause of hypothyroidism in developed countries. The exact pathomechanism behind it has not been clearly established; however, an interplay of genetic susceptibility, environmental triggers (including diet) and epigenetic factors seems to be involved. Among...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385892/ https://www.ncbi.nlm.nih.gov/pubmed/37512046 http://dx.doi.org/10.3390/medicina59071234 |
_version_ | 1785081525404958720 |
---|---|
author | Gontarz-Nowak, Katarzyna Szklarz, Michał Szychlińska, Magdalena Matuszewski, Wojciech Bandurska-Stankiewicz, Elżbieta |
author_facet | Gontarz-Nowak, Katarzyna Szklarz, Michał Szychlińska, Magdalena Matuszewski, Wojciech Bandurska-Stankiewicz, Elżbieta |
author_sort | Gontarz-Nowak, Katarzyna |
collection | PubMed |
description | Hashimoto’s disease (HD) is the most common cause of hypothyroidism in developed countries. The exact pathomechanism behind it has not been clearly established; however, an interplay of genetic susceptibility, environmental triggers (including diet) and epigenetic factors seems to be involved. Among the latter, increasingly more attention has been paid to some hormonally active substances, known as endocrine disruptors, which are commonly used worldwide. HD has become a condition widely reported in the media, acting as a culprit for inexplicable weight gain, chronic fatigue or weakness. Nevertheless, the recognition of HD is undeniably increasing and represents a major public health burden. At the same time, improving access to imaging tests has increased the number of incidentally diagnosed adrenal tumors. Above all, the widespread use of chest computed tomography (CT) due to the COVID-19 pandemic has contributed to frequent incidental detection of adrenal lesions. Fortunately, a vast majority of these findings are asymptomatic benign tumors with no excessive hormonal activity, and therefore, they are defined as adrenal incidentalomas (AIs). Interestingly, recent studies have indicated that patients with AIs are more prone to obesity and insulin resistance. Although mutual relationships between the thyroid and the adrenal glands have been studied widely, still, little is known about the possible pathophysiological associations between thyroid autoimmunity and the occurrence of adrenal incidentalomas. This article presents a brief review of the common endocrine disorders with a special focus on the frequently coexisting insulin resistance and/or obesity. Furthermore, in response to the recent growing interest in endocrine disruptors, with their transgenerational epigenetic effects that influence hormonal system function, a concise overview of the topic has also been included. |
format | Online Article Text |
id | pubmed-10385892 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103858922023-07-30 A Brief Look at Hashimoto’s Disease, Adrenal Incidentalomas, Obesity and Insulin Resistance—Could Endocrine Disruptors Be the Other Side of the Same Coin? Gontarz-Nowak, Katarzyna Szklarz, Michał Szychlińska, Magdalena Matuszewski, Wojciech Bandurska-Stankiewicz, Elżbieta Medicina (Kaunas) Review Hashimoto’s disease (HD) is the most common cause of hypothyroidism in developed countries. The exact pathomechanism behind it has not been clearly established; however, an interplay of genetic susceptibility, environmental triggers (including diet) and epigenetic factors seems to be involved. Among the latter, increasingly more attention has been paid to some hormonally active substances, known as endocrine disruptors, which are commonly used worldwide. HD has become a condition widely reported in the media, acting as a culprit for inexplicable weight gain, chronic fatigue or weakness. Nevertheless, the recognition of HD is undeniably increasing and represents a major public health burden. At the same time, improving access to imaging tests has increased the number of incidentally diagnosed adrenal tumors. Above all, the widespread use of chest computed tomography (CT) due to the COVID-19 pandemic has contributed to frequent incidental detection of adrenal lesions. Fortunately, a vast majority of these findings are asymptomatic benign tumors with no excessive hormonal activity, and therefore, they are defined as adrenal incidentalomas (AIs). Interestingly, recent studies have indicated that patients with AIs are more prone to obesity and insulin resistance. Although mutual relationships between the thyroid and the adrenal glands have been studied widely, still, little is known about the possible pathophysiological associations between thyroid autoimmunity and the occurrence of adrenal incidentalomas. This article presents a brief review of the common endocrine disorders with a special focus on the frequently coexisting insulin resistance and/or obesity. Furthermore, in response to the recent growing interest in endocrine disruptors, with their transgenerational epigenetic effects that influence hormonal system function, a concise overview of the topic has also been included. MDPI 2023-06-30 /pmc/articles/PMC10385892/ /pubmed/37512046 http://dx.doi.org/10.3390/medicina59071234 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Gontarz-Nowak, Katarzyna Szklarz, Michał Szychlińska, Magdalena Matuszewski, Wojciech Bandurska-Stankiewicz, Elżbieta A Brief Look at Hashimoto’s Disease, Adrenal Incidentalomas, Obesity and Insulin Resistance—Could Endocrine Disruptors Be the Other Side of the Same Coin? |
title | A Brief Look at Hashimoto’s Disease, Adrenal Incidentalomas, Obesity and Insulin Resistance—Could Endocrine Disruptors Be the Other Side of the Same Coin? |
title_full | A Brief Look at Hashimoto’s Disease, Adrenal Incidentalomas, Obesity and Insulin Resistance—Could Endocrine Disruptors Be the Other Side of the Same Coin? |
title_fullStr | A Brief Look at Hashimoto’s Disease, Adrenal Incidentalomas, Obesity and Insulin Resistance—Could Endocrine Disruptors Be the Other Side of the Same Coin? |
title_full_unstemmed | A Brief Look at Hashimoto’s Disease, Adrenal Incidentalomas, Obesity and Insulin Resistance—Could Endocrine Disruptors Be the Other Side of the Same Coin? |
title_short | A Brief Look at Hashimoto’s Disease, Adrenal Incidentalomas, Obesity and Insulin Resistance—Could Endocrine Disruptors Be the Other Side of the Same Coin? |
title_sort | brief look at hashimoto’s disease, adrenal incidentalomas, obesity and insulin resistance—could endocrine disruptors be the other side of the same coin? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385892/ https://www.ncbi.nlm.nih.gov/pubmed/37512046 http://dx.doi.org/10.3390/medicina59071234 |
work_keys_str_mv | AT gontarznowakkatarzyna abrieflookathashimotosdiseaseadrenalincidentalomasobesityandinsulinresistancecouldendocrinedisruptorsbetheothersideofthesamecoin AT szklarzmichał abrieflookathashimotosdiseaseadrenalincidentalomasobesityandinsulinresistancecouldendocrinedisruptorsbetheothersideofthesamecoin AT szychlinskamagdalena abrieflookathashimotosdiseaseadrenalincidentalomasobesityandinsulinresistancecouldendocrinedisruptorsbetheothersideofthesamecoin AT matuszewskiwojciech abrieflookathashimotosdiseaseadrenalincidentalomasobesityandinsulinresistancecouldendocrinedisruptorsbetheothersideofthesamecoin AT bandurskastankiewiczelzbieta abrieflookathashimotosdiseaseadrenalincidentalomasobesityandinsulinresistancecouldendocrinedisruptorsbetheothersideofthesamecoin AT gontarznowakkatarzyna brieflookathashimotosdiseaseadrenalincidentalomasobesityandinsulinresistancecouldendocrinedisruptorsbetheothersideofthesamecoin AT szklarzmichał brieflookathashimotosdiseaseadrenalincidentalomasobesityandinsulinresistancecouldendocrinedisruptorsbetheothersideofthesamecoin AT szychlinskamagdalena brieflookathashimotosdiseaseadrenalincidentalomasobesityandinsulinresistancecouldendocrinedisruptorsbetheothersideofthesamecoin AT matuszewskiwojciech brieflookathashimotosdiseaseadrenalincidentalomasobesityandinsulinresistancecouldendocrinedisruptorsbetheothersideofthesamecoin AT bandurskastankiewiczelzbieta brieflookathashimotosdiseaseadrenalincidentalomasobesityandinsulinresistancecouldendocrinedisruptorsbetheothersideofthesamecoin |